Bank Of New York Mellon Corp Codiak Bio Sciences, Inc. Transaction History

Bank Of New York Mellon Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.82 - $3.19 $41 - $159	-50 Reduced 0.28%	18,046 $14,000
Q2 2022 Aug 15, 2022	SELL	$2.24 - $6.96 $81,576 - $253,469	-36,418 Reduced 66.8%	18,096 $52,000
Q1 2022 May 11, 2022	BUY	$4.3 - $12.95 $73,280 - $220,693	17,042 Added 45.48%	54,514 $343,000
Q4 2021 Feb 11, 2022	BUY	$10.0 - $16.78 $8,350 - $14,011	835 Added 2.28%	37,472 $417,000
Q3 2021 Nov 12, 2021	BUY	$15.58 - $22.88 $81,530 - $119,731	5,233 Added 16.66%	36,637 $598,000
Q2 2021 Aug 11, 2021	BUY	$11.72 - $26.81 $184,367 - $421,748	15,731 Added 100.37%	31,404 $581,000
Q1 2021 May 13, 2021	SELL	$13.49 - $31.53 $27,775 - $64,920	-2,059 Reduced 11.61%	15,673 $236,000
Q4 2020 Feb 09, 2021	BUY	$7.9 - $32.3 $140,082 - $572,743	17,732 New	17,732 $572,000

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.